21 – 30 of 140
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Gene therapy for Parkinson's disease : Disease modification by GDNF family of ligands
(
- Contribution to journal › Scientific review
- 2016
-
Mark
Interaction between the obesity-risk gene FTO and the dopamine D2 receptor gene ANKK1/TaqIA on insulin sensitivity
(
- Contribution to journal › Article
-
Mark
In vivo dopamine agonist properties of rotigotine : Role of D1 and D2 receptors
(
- Contribution to journal › Article
-
Mark
Two-step production of monoamines in monoenzymatic cells in the spinal cord : A different control strategy of neurotransmitter supply?
(
- Contribution to journal › Scientific review
- 2015
-
Mark
Blockade of growth hormone secretagogue receptor 1A signaling by JMV 2959 attenuates the NMDAR antagonist, phencyclidine-induced impairments in prepulse inhibition
(
- Contribution to journal › Article
-
Mark
Dopamine and Huntington's disease
(
- Contribution to journal › Article
-
Mark
Strain dependence of adolescent Cannabis influence on heroin reward and mesolimbic dopamine transmission in adult Lewis and Fischer 344 rats
(
- Contribution to journal › Article
- 2014
-
Mark
Novel strategies for enzyme replacement with gene therapy in models of Parkinson’s disease
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Nigral 6-hydroxydopamine lesion impairs performance in a lateralised choice reaction time task-Impact of training and task parameters
(
- Contribution to journal › Article
-
Mark
Modelling of a targeted nanotherapeutic 'stroma' to deliver the cytokine LIF, or XAV939, a potent inhibitor of Wnt-β-catenin signalling, for use in human fetal dopaminergic grafts in Parkinson's disease
(
- Contribution to journal › Article